Healthy AIClinical safety protocol
Safety boundary: keep all recommendations subject to qualified human verification. Do not use this protocol for diagnosis, treatment, triage, or emergency decisions.
PROTOCOL 01 / READINESS

Clinical safety readiness

Record only controls supported by reviewable evidence. Completing a control records presence; it does not validate the evidence.

Weighted readiness
0/100
External evaluation contraindicated

Keep the workflow in an internal sandbox until every critical barrier is closed and verified by a qualified reviewer.

STEP 01

Define boundaries

Fix intended use, exclusions, and deterministic escalation before evaluation.

Medical limitation disclaimers

Contraindication

Every AI-facing flow states that Healthy AI readiness is not medical advice, diagnosis, treatment guidance, or a safety certification.

Add plain-language limitation copy to onboarding, AI output, summaries, exports, and handoff screens.

Clinical risk classification

Contraindication

The prototype has a documented risk class for wellness, admin, decision support, triage, diagnosis, medication, or emergency-adjacent use.

Classify the workflow, document excluded clinical scenarios, and route higher-risk use cases to qualified clinical and regulatory review.

Escalation and emergency routing

Contraindication

The prototype identifies urgent symptoms, self-harm, medication, pediatric, pregnancy, and emergency-care boundaries with a non-AI escalation route.

Define escalation triggers, emergency copy, support ownership, and a hard stop for out-of-scope scenarios.

STEP 02

Assign authority

Name accountable reviewers and establish governance and privacy controls.

Named human review owner

Contraindication

A qualified reviewer is accountable for approving evaluation scope, reviewing edge cases, and blocking unsafe release paths.

Name the reviewer, define their sign-off checklist, and require approval before any external pilot.

Governance decision record

Contraindication

The team has a written decision record covering intended users, excluded uses, owners, sign-off roles, and review cadence.

Create a governance record with owners, intended-use boundaries, excluded uses, approval cadence, and change-control rules.

Privacy and data minimization

Contraindication

The team has documented PHI/PII boundaries, consent, retention, redaction, access control, and deletion handling.

Document what data is allowed, what is prohibited, how it is stored, who can access it, and when it is deleted.

STEP 03

Verify evidence

Trace claims and test representative cases, slices, and known failures.

Evidence and test traceability

Evidence missing

Claims, prompts, known limitations, test cases, and observed failures are linked to a traceable evidence log.

Create an evidence log that ties claims to sources, test cases, failure examples, and reviewer notes.

Validation dataset and slice coverage

Evidence missing

Evaluation data covers representative cases, edge cases, demographic slices, language needs, and known failure modes.

Define validation slices, sample minimums, acceptance thresholds, and reviewer notes for failures and borderline cases.

STEP 04

Control release

Set monitoring, incident, rollback, and human handoff gates.

Deployment monitoring gates

Evidence missing

The rollout plan includes monitoring signals, alert thresholds, staged exposure, user feedback review, and rollback criteria.

Define staged rollout gates, production monitors, alert owners, rollback triggers, and post-launch review cadence.

Incident response and rollback

Evidence missing

The team has an incident owner, severity levels, response times, rollback criteria, and a feedback-to-fix workflow.

Assign an incident owner, define severity levels, and connect feedback reports to the release-blocking review queue.

Human verification gate

A checked control records team readiness only. A qualified reviewer must inspect the underlying evidence, confirm scope, and explicitly authorize any controlled evaluation.

Healthy AI Clinical Safety Protocol HA-CSP-01Local deterministic assessment. Qualified human authorization required.